China’s economy is proving resilient in choppy global waters, with foreign investors doubling down on high-tech opportunities despite geopolitical headwinds. According to new data, over 12,600 foreign-invested enterprises set up shop in Q1 2025—a 4.3% jump from last year.
While total FDI dipped slightly to $37.2 billion, March saw a 13.2% rebound—a sign that global firms are quietly betting on China’s long-term potential. Analysts blame earlier declines on U.S. tariffs and geopolitical drama, but as one expert told China Media Group, “Innovation never sleeps.”
Check where the cash is flowing:
E-commerce investments DOUBLED (up 100.5%)
Biopharma and aerospace sectors surged 63.8% and 42.5%
EU and ASEAN investments jumped 11.7% and 56.2%
Big Pharma’s all-in: Sanofi and AstraZeneca are expanding R&D hubs, while global automaker Valeo praised China’s “policy stability and innovation ecosystem.” Meanwhile, 58% of foreign firms in a AmCham survey still rank China as a top-3 investment target.
China’s counterpunch? Opening telecommunication trials for Siemens and slashing red tape—the national negative list now has just 29 restrictions. With 155 new market access measures, from healthcare to TikTok-style cross-border e-commerce, the message is clear: “We’re open for smart money.”
NewspaperAmigo – Your Global News Buddy 
According to new data, over 12,600 foreign-invested enterprises set up shop in Q1 2025—a 4.3% jump from last year.
E-commerce investments DOUBLED (up 100.5%)
Biopharma and aerospace sectors surged 63.8% and 42.5%
EU and ASEAN investments jumped 11.7% and 56.2%
message is clear: “We’re open for smart money.”
, Health Officials Confirm
